Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Marshall Bedder

Psychiatry Augusta, GA Medical Doctor

NPI 1013906833 CMS profile 137138

1120 15Th St, Augusta, GA 30912

Open in the dashboard

General payments

$182,344

255 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Marshall Bedder of Augusta, GA is reported in the CMS Open Payments database as having received $182,344 across 255 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $42,263 16
2024 General $14,985 20
2023 General $1,517 19
2022 General $13,502 27
2021 General $27,591 23
2020 General $35,016 45
2019 General $47,469 105

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marshall Bedder
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Marshall Bedder were reported at $42,263. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Marshall Bedder Psychiatry median Middle half National median
2019 $47,469 $184 $59–$605 $163
2020 $35,016 $119 $36–$372 $114
2021 $27,591 $143 $43–$576 $132
2022 $13,502 $153 $50–$590 $149
2023 $1,517 $170 $56–$651 $160
2024 $14,985 $179 $57–$673 $164
2025 $42,263 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $110,330 135 payments
  2. Kedplasma LLC $55,025 17 payments
  3. SPR Therapeutics, Inc $9,198 14 payments
  4. International Rehabilitative Sciences, Inc $1,815 6 payments
  5. Vertiflex, Inc. $1,627 9 payments
  6. Nevro Corp. $1,326 14 payments
  7. Medtronic, Inc. $671 11 payments
  8. Saluda Medical Americas, Inc. $516 6 payments
  9. Abbott Laboratories $260 3 payments
  10. Painteq LLC $237 3 payments
  11. Other $1,340 37 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $91,025 40 payments
  2. Consulting Fee $72,425 30 payments
  3. Food and Beverage $10,378 160 payments
  4. Travel and Lodging $7,327 24 payments
  5. Long term medical supply or device loan $1,189 1 payment
Products named General payments · program years 2019–2025
  1. SPECTRA WAVEWRITER Pain Management $65,062 63 payments
  2. WAVEWRITER ALPHA Pain Management $9,505 6 payments
  3. SPRINT PNS System $9,198 14 payments
  4. Superion $7,200 4 payments
  5. GENERAL - PAIN MANAGEMENT $5,531 9 payments
  6. SPECTRA WAVEWRITER Pain Management $3,996 3 payments
  7. WAVEWRITER ALPHA WaveWriter Alpha $3,600 2 payments
  8. General - Therapies $3,600 2 payments
  9. GENERAL PAIN MANAGEMENT $3,354 15 payments
  10. GENERAL THERAPIES $2,976 13 payments
  11. Other $13,028 117 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

255 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record